MedTrace Logo

Evaluation of 3 Intraocular Lenses Following Lens Extraction

NCT01122576 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2014-03-28

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.

Conditions

  • Cataract

Interventions

DEVICE

Crystalens AO

Crystalens AO surgically implanted bilaterally. Study observation up to 180 days.

DEVICE

ReSTOR

ReSTOR surgically implanted bilaterally. Study observation up to 180 days.

DEVICE

Tecnis Multifocal IOL

Tecnis surgically implanted bilaterally. Study observation up to 180 days.

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Omid Khodai, OD, RAC · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-06-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01122576 on ClinicalTrials.gov